DERMAPATH: what changed
What changed
DERMAPATH
filed annual accounts (NBB)
Net result for the year
-€1,534
2024 · -€1,000-€534
Equity
-€5,241
2024 · -€3,707-€1,534
Cash
€9,646
2024 · €8,505+€1,141
Balance sheet total
€1.1m
2024 · €1.1m-€1,534
Largest movements
Assets
No asset line moved by more than 1% of the balance sheet total.
Equity and liabilities
No liability line moved by more than 1% of the balance sheet total.
Income statement
- Other operating charges +€583
up €583 (+152%), from €384 to €968
- Gross operating margin +€49
up €49 (+9.6%), from -€512 to -€463
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
-€1,000
Gross operating margin
+€49
Other operating charges
-€583
Result 2025
-€1,534
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€1,141
Investment
€0
Financing
€0
Cash 2024
€8,505
From operations (derived)
+€1,141
Net result for the year
-€1,534
Receivables within one year
+€2,676
Cash 2025
€9,646
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,114,043 | €1,112,509 | -€1,534 | -0.1% |
| Fixed assets | 21/28 | €772,000 | €772,000 | = | 0.0% |
| Financial fixed assets | 28 | €772,000 | €772,000 | = | 0.0% |
| Current assets | 29/58 | €342,043 | €340,509 | -€1,534 | -0.4% |
| Amounts receivable within one year | 40/41 | €333,538 | €330,863 | -€2,676 | -0.8% |
| Trade receivables | 40 | €333,538 | €330,863 | -€2,676 | -0.8% |
| Cash at bank and in hand | 54/58 | €8,505 | €9,646 | +€1,141 | +13.4% |
| Total equity and liabilities | 10/49 | €1,114,043 | €1,112,509 | -€1,534 | -0.1% |
| Equity | 10/15 | -€3,707 | -€5,241 | -€1,534 | -41.4% |
| Contributions | 10/11 | €100 | €100 | = | 0.0% |
| Contributions outside capital | 11 | €100 | €100 | = | 0.0% |
| Share premium | 1100/10 | €100 | €100 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€3,807 | -€5,341 | -€1,534 | -40.3% |
| Amounts payable | 17/49 | €1,117,750 | €1,117,750 | = | 0.0% |
| Amounts payable after more than one year | 17 | €1,117,750 | €1,117,750 | = | 0.0% |
| Other amounts payable | 178/9 | €1,117,750 | €1,117,750 | = | 0.0% |
| Other operating charges | 640/8 | €384 | €968 | +€583 | +152% |
| Gross operating margin | 9900 | -€512 | -€463 | +€49 | +9.6% |
| Operating profit (loss) | 9901 | -€896 | -€1,430 | -€534 | -59.6% |
| Financial charges | 65/66B | €104 | €104 | = | 0.0% |
| Recurring financial charges | 65 | €104 | €104 | = | 0.0% |
| Profit (loss) for the period before taxes | 9903 | -€1,000 | -€1,534 | -€534 | -53.4% |
| Profit (loss) for the period | 9904 | -€1,000 | -€1,534 | -€534 | -53.4% |
| Profit (loss) for the period to be appropriated | 9905 | -€1,000 | -€1,534 | -€534 | -53.4% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 March 2024 and 31 March 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 7 November 2026 via checked.be.